Quick Answer
PLUS THERAPEUTICS, INC. reported Net Income of -$22.39 million for fiscal year 2025.
PLUS THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$22.39M | -72.5% |
| 2024 | -$12.98M | +2.5% |
| 2023 | -$13.32M | +34.3% |
| 2022 | -$20.27M | -51.3% |
| 2021 | -$13.40M | -62.6% |
| 2020 | -$8.24M | +24.3% |
| 2019 | -$10.89M | +13.8% |
| 2018 | -$12.63M | +44.3% |
| 2017 | -$22.69M | -2.9% |
| 2016 | -$22.05M | -17.6% |
| 2015 | -$18.74M | +49.8% |
| 2014 | -$37.37M | -42.8% |
| 2013 | -$26.18M | +18.9% |
| 2012 | -$32.28M | +0.5% |
| 2011 | -$32.45M | -18.0% |
| 2010 | -$27.49M | -18.4% |
| 2009 | -$23.22M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.42M | -53.9% | -185.9% |
| June 30, 2025 | $5.15M | +275.2% | +129.6% |
| March 31, 2025 | -$17.40M | -433.6% | -505.5% |
| September 30, 2024 | -$2.87M | +10.7% | +2.2% |
| June 30, 2024 | -$2.94M | -98.4% | +9.8% |
| March 31, 2024 | -$3.26M | +32.1% | -1.3% |
| September 30, 2023 | -$3.22M | +38.3% | -117.2% |
| June 30, 2023 | -$1.48M | +71.9% | +69.2% |
- PLUS THERAPEUTICS, INC. showed a decrease of -72.5% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, PLUS THERAPEUTICS, INC.’s net income has grown by 3.6% (from -$23.22 million to -$22.39 million).
- The most recent figure is from PLUS THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: